Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary disorder (COPD), is receiving high marks from doctors and patients. Ohtuvayre is the first new inhaled COPD ...

belief that Ohtuvayre's bronchodilator and non-steroidal anti-inflammatory activity can re-define the COPD treatment paradigm." The encouraging sales figures come at a time when treatment options ...

Dupixent becomes the first-ever targeted therapy for patients with COPD, the first biologic for the disease, and the first new treatment approach in Europe in over a decade. It has been cleared ...

Individuals with COPD have an increased risk of mortality from exposure to extreme temperatures, both heat and cold, as well as from exposure to air pollution. Climate change is affecting the health ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

2010;67(13):1061-1069. Considering all of the data and their limitations, questions still remain regarding the optimal treatment of COPD exacerbations. The data of deJong et al. [30] showed no ...

People with COPD and CVD vs CVD alone were less likely to receive preventive cardiac care such as medications, cardiologist referrals, and coronary bypass graft surgery. Patients with chronic ...

17, 2025 — A clinical trial conducted in a neonatal intensive care unit has identified a new treatment protocol to ... chronic obstructive pulmonary disease (COPD), and ...

It is with heavy hearts that we announce the passing of Mrs. Joyce Imogene Camden Vest, age 84, who left us peacefully on Monday, April 14h, 2025. Imogene was born on July 20, 1940, to the late ...

The Beef Improvement Federation (BIF) presented Vest Ranches the BIF Commercial Producer of the Year Award June 9 during the group’s annual meeting and symposium online. This national award is ...